Clinical Trial: A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07600554) titled 'A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer' on May 06.

Brief Summary: The aim of this study is to assess the safety and dosimetry of imaging with [68Ga]Ga-OncoACP3 in patients with prostate cancer.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Prostate Cancer

Intervention: DRUG: [68Ga]Ga-OncoACP3

Single intravenous bolus injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Philogen S.p.A.

Disclaimer: Curated by HT Syndication....